GenomeDx Biosciences Implements Clarity LIMS for use in Clinical Lab
News Jan 28, 2015
Genologics has announced that GenomeDx Biosciences has implemented GenoLogics’ laboratory information management system, Clarity LIMS, to support whole transcriptome analysis workflows as part of their mission to address unmet clinical needs in the management of prostate cancer. Headquartered in Vancouver BC, GenomeDx will use Clarity LIMS in its CLIA-certified lab in San Diego, CA.
In the U.S. alone, there are an estimated 2.5 million men who are living with prostate cancer. An estimated 230,000 are diagnosed each year with over 100,000 undergoing surgery to treat their cancer. According to clinical risk assessment, nearly half of men should be considered for post-surgery radiation even though their cancer may not recur.
Using their genomic test, the Decipher® Prostate Cancer Classifier, GenomeDx is able to predict the probability of cancer spread for men after surgery. Clinicians can then use this information, along with other clinical factors, to better guide postoperative treatment decisions and in certain men, avoid the side effects and high costs associated with treatment.
GenomeDx will use the cloud-based version of Clarity LIMS to support samples processed using the Decipher Test. Built specifically for genomics labs, Clarity LIMS provides end-to-end sample tracking, automation, preconfigured workflows, and superior usability.
According to Andy Katz, PhD and Chief Operating Officer at GenomeDx, “We chose Clarity LIMS because it supports our laboratory quality assurance policies and it fits into our existing environment through use of the robust application programming interface (API).”
“We are happy to support GenomeDx and their transformational work to personalize treatment for cancer patients,” says Michael Ball, CEO of GenoLogics. “We look forward to working with them to optimize Clarity LIMS so they can continue to provide patients with actionable treatment information.”
Cancer Cells’ Energy Source Blocked by Natural CompoundNews
Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.READ MORE
Unchained Labs Unveils LEA 9 Software Making Workflows EasyNews
Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, released its LEA 9 software, making Freeslate and Junior automation systems way more accessible.READ MORE
First Ever Online Event Focused on Cannabis ScienceNews
Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.READ MORE